332 related articles for article (PubMed ID: 37476546)
1. Inflammatory Bowel Disease-Associated Colorectal Cancer: Translational and Transformational Risks Posed by Exogenous Free Hemoglobin Alpha Chain, A By-Product of Extravasated Erythrocyte Macrophage Erythrophagocytosis.
Bragg MA; Breaux WA; M'Koma AE
Medicina (Kaunas); 2023 Jul; 59(7):. PubMed ID: 37476546
[TBL] [Abstract][Full Text] [Related]
2. Implications of the colonic deposition of free hemoglobin-α chain: a previously unknown tissue by-product in inflammatory bowel disease.
Myers JN; Schäffer MW; Korolkova OY; Williams AD; Gangula PR; M'Koma AE
Inflamm Bowel Dis; 2014 Sep; 20(9):1530-47. PubMed ID: 25078150
[TBL] [Abstract][Full Text] [Related]
3. Review article: the role of oxidative stress in pathogenesis and treatment of inflammatory bowel diseases.
Piechota-Polanczyk A; Fichna J
Naunyn Schmiedebergs Arch Pharmacol; 2014 Jul; 387(7):605-20. PubMed ID: 24798211
[TBL] [Abstract][Full Text] [Related]
4. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
5. Colitis-associated colorectal cancer in patients with inflammatory bowel disease.
Baek SJ; Kim SH
Minerva Chir; 2017 Dec; 72(6):520-529. PubMed ID: 29072418
[TBL] [Abstract][Full Text] [Related]
6. Intestinal oxidative damage in inflammatory bowel disease: semi-quantification, localization, and association with mucosal antioxidants.
Kruidenier L; Kuiper I; Lamers CB; Verspaget HW
J Pathol; 2003 Sep; 201(1):28-36. PubMed ID: 12950014
[TBL] [Abstract][Full Text] [Related]
7. A superoxide dismutase/catalase mimetic nanomedicine for targeted therapy of inflammatory bowel disease.
Zhang Q; Tao H; Lin Y; Hu Y; An H; Zhang D; Feng S; Hu H; Wang R; Li X; Zhang J
Biomaterials; 2016 Oct; 105():206-221. PubMed ID: 27525680
[TBL] [Abstract][Full Text] [Related]
8. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
Pedersen G
Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
[TBL] [Abstract][Full Text] [Related]
9. The implications of oxidative stress and antioxidant therapies in Inflammatory Bowel Disease: Clinical aspects and animal models.
Balmus IM; Ciobica A; Trifan A; Stanciu C
Saudi J Gastroenterol; 2016; 22(1):3-17. PubMed ID: 26831601
[TBL] [Abstract][Full Text] [Related]
10. The impact of mangiferin from Belamcanda chinensis on experimental colitis in rats.
Szandruk M; Merwid-Ląd A; Szeląg A
Inflammopharmacology; 2018 Apr; 26(2):571-581. PubMed ID: 28337639
[TBL] [Abstract][Full Text] [Related]
11. Neurotensin receptor 1 overexpression in inflammatory bowel diseases and colitis-associated neoplasia.
Gui X; Liu S; Yan Y; Gao Z
World J Gastroenterol; 2013 Jul; 19(28):4504-10. PubMed ID: 23901225
[TBL] [Abstract][Full Text] [Related]
12. A nanoparticulate dual scavenger for targeted therapy of inflammatory bowel disease.
Shi C; Dawulieti J; Shi F; Yang C; Qin Q; Shi T; Wang L; Hu H; Sun M; Ren L; Chen F; Zhao Y; Liu F; Li M; Mu L; Liu D; Shao D; Leong KW; She J
Sci Adv; 2022 Jan; 8(4):eabj2372. PubMed ID: 35089791
[TBL] [Abstract][Full Text] [Related]
13. Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause?
Rezaie A; Parker RD; Abdollahi M
Dig Dis Sci; 2007 Sep; 52(9):2015-21. PubMed ID: 17404859
[TBL] [Abstract][Full Text] [Related]
14. Oxidative stress, hormones, and effects of natural antioxidants on intestinal inflammation in inflammatory bowel disease.
Sahoo DK; Heilmann RM; Paital B; Patel A; Yadav VK; Wong D; Jergens AE
Front Endocrinol (Lausanne); 2023; 14():1217165. PubMed ID: 37701897
[TBL] [Abstract][Full Text] [Related]
15. Subsets of mononuclear phagocytes are enriched in the inflamed colons of patients with IBD.
Liu H; Dasgupta S; Fu Y; Bailey B; Roy C; Lightcap E; Faustin B
BMC Immunol; 2019 Nov; 20(1):42. PubMed ID: 31718550
[TBL] [Abstract][Full Text] [Related]
16. Serotonin regulates innate immune responses of colon epithelial cells through Nox2-derived reactive oxygen species.
Regmi SC; Park SY; Ku SK; Kim JA
Free Radic Biol Med; 2014 Apr; 69():377-89. PubMed ID: 24524998
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic Potential of Triptolide as an Anti-Inflammatory Agent in Dextran Sulfate Sodium-Induced Murine Experimental Colitis.
Tang B; Zhu J; Zhang B; Wu F; Wang Y; Weng Q; Fang S; Zheng L; Yang Y; Qiu R; Chen M; Xu M; Zhao Z; Ji J
Front Immunol; 2020; 11():592084. PubMed ID: 33240279
[TBL] [Abstract][Full Text] [Related]
18. Imbalanced secondary mucosal antioxidant response in inflammatory bowel disease.
Kruidenier L; Kuiper I; Van Duijn W; Mieremet-Ooms MA; van Hogezand RA; Lamers CB; Verspaget HW
J Pathol; 2003 Sep; 201(1):17-27. PubMed ID: 12950013
[TBL] [Abstract][Full Text] [Related]
19. Effects of iron and iron chelation in vitro on mucosal oxidant activity in ulcerative colitis.
Millar AD; Rampton DS; Blake DR
Aliment Pharmacol Ther; 2000 Sep; 14(9):1163-8. PubMed ID: 10971233
[TBL] [Abstract][Full Text] [Related]
20. ROS Scavenging and inflammation-directed polydopamine nanoparticles regulate gut immunity and flora therapy in inflammatory bowel disease.
Bao M; Wang K; Li J; Li Y; Zhu H; Lu M; Zhang Y; Fan Q; Han L; Wang K; Wang D; Gao Y; Peng B; Ming Z; Liu W
Acta Biomater; 2023 Apr; 161():250-264. PubMed ID: 36863680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
